問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
馮思中
下載
2022-04-01 - 2026-06-30
Condition/Disease
Test Drug
Participate Sites6Sites
Recruiting5Sites
2024-01-26 - 2029-02-28
Participate Sites5Sites
2020-10-16 - 2028-06-26
Recruiting6Sites
2025-06-30 - 2032-05-01
2025-04-01 - 2027-12-31
Participate Sites4Sites
Recruiting4Sites
2016-11-01 - 2022-10-28
metastatic hormone-sensitive prostate cancer
BAY 1841788/ODM-201(Darlutamide)
Participate Sites8Sites
2022-01-01 - 2025-12-31
Participate Sites2Sites
Recruiting2Sites
2022-01-01 - 2024-12-31
Metastatic Prostate Cancer
Ga-68 PSMA ligand
Participate Sites1Sites
Recruiting1Sites
2018-11-01 - 2022-05-31
2020-12-01 - 2022-03-22
全部
